Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
GB Sciences, Inc. is a biopharmaceutical company developing plant-inspired medicines, primarily from cannabis and traditional herbs. Through its Canadian subsidiary, it creates patented formulations targeting diseases like Parkinson’s, pain, inflammation, and mental health conditions. Utilizing AI-driven drug discovery and strategic partnerships, it focuses on patent-protected, minimally complex mixtures for prescription therapies, aiming to address unmet medical needs in global markets.
This description was generated via AI from an annual report. Updated about 1 year ago.